Drug Shortage Report for SANDOZ DORZOLAMIDE/TIMOLOL

Last updated on 2024-07-09 History
Report ID 232471
Drug Identification Number 02344351
Brand name SANDOZ DORZOLAMIDE/TIMOLOL
Common or Proper name DORZOLAMIDE/TIMOLOL
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) TIMOLOL DORZOLAMIDE
Strength(s) 5MG 20MG
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 10ML LDP
ATC code S01ED
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2024-07-08
Estimated end date 2024-10-04
Actual end date
Shortage status Actual shortage
Updated date 2024-07-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2024-07-09 English Compare
v2 2024-07-08 French Compare
v1 2024-07-08 English Compare

Showing 1 to 3 of 3